Declan Irvine eyes a podium finish at the Sea Otter Europe gravel race in Girona, needing a top 25% result to secure qualification for his third UCI Gravel World Championships in Western Australia. The Team Novo Nordisk pro’s bid follows a grueling 2025 battle with testicular cancer and type 1 diabetes.
Fantasy & Market Impact
From the Road to the Gravel Grinder
For Declan Irvine, navigating the physical demands of professional cycling has always required an extraordinary level of physiological management. Diagnosed with type 1 diabetes at age 12, the Australian multi-discipline rider learned early on how to treat his body as a high-performance engine. Before joining Team Novo Nordisk full-time for road racing in 2019, he built an impressive endurance resume with junior triathlons, a representation of Australia at the World Duathlon Championships, and state-level road and criterium titles in New South Wales.
When he integrated gravel events into his road program in 2022, his trajectory pointed sharply upward. By 2024, he secured a top-10 stage finish at the Tour of Hainan, a 10th-place result at Gravelista in Australia, a 21st at Big Sugar Gravel, and a 24th at Unbound Gravel 200 despite battling a mechanical failure. But just as his gravel career gained momentum, a routine medical check shifted his entire life perspective off the racing line.
The Life-Changing Call in Girona
The turning point arrived one month after a frustrating mechanical setback at Unbound Gravel in Kansas. While at an elevation camp with Team Novo Nordisk following the Baloise Belgium Tour, Irvine felt an unusual sensation in his groin and sought a medical evaluation. At a clinic in Girona, a non-English-speaking ultrasound technician delivered a chilling diagnosis. As Irvine recalled of the moment, “He’s saying ‘no good’ and then ‘cancer’. I start bawling my eyes out, because I lost my mind.”
Further medical examinations confirmed testicular cancer. However, Irvine’s deep familiarity with his own biometric markers proved critical during the diagnostic phase. Initial hospital blood panels showed a severely elevated Creatine Kinase (CK) biomarker, an indicator normally associated with severe muscle damage from intense athletic training. Medical staff initially pointed to this marker as grounds for immediate chemotherapy.
Knowing his body intimately, Irvine pushed back. He requested a week of complete rest off the bike to allow his muscles to recover and clear the biomarker naturally. When a follow-up test a week later showed his CK levels had returned to normal, doctors confirmed the elevation was exercise-induced rather than cancer-driven, allowing him to bypass chemotherapy entirely in favor of surgery.
The Road Back to the World Championship Start Line
Following two weeks of being bed-bound in Girona with his partner Courtney Wevers providing physical and emotional support, Irvine faced a long rehabilitation. Yet, just three months after surgery, he was back on his bike at the UCI Gravel World Championships in the Netherlands. Though he finished 26 minutes behind winner Florian Vermeersch, his primary victory was simply pinning on the green and gold kit and returning to competition.
| Event / Race | Discipline | Season | Result / Highlight |
|---|---|---|---|
| Unbound Gravel 200 | Gravel | 2024 | 24th place (despite mechanical) |
| UCI Gravel World Championships | Gravel | 2024 | Returned to racing 3 months post-surgery |
| La Roue Tourangelle | Road | 2026 | Named most aggressive rider |
| Unbound Gravel 200 (Open Category) | Gravel | 2026 | Finished 3rd |
| Tour of Denmark (2.Pro) | Road | 2026 | Helped team leader Filippo Ridolfo to GC top-25 |
The 2026 season marked a complete return to professional form. Racing for Team Novo Nordisk, Irvine earned the most aggressive rider accolade at La Roue Tourangelle, competed in the Tour of Turkey and Tour of Denmark, and claimed third place in the open category at the Unbound Gravel 200 in Kansas.
Now, as he targets a strong finish at Sea Otter Europe in Girona, Irvine is chasing the top 25% placement required to automatically qualify for his third UCI Gravel World Championships. With the championship moving to Nannup, Western Australia, a successful qualification bid would bring him back to his home country for what he describes as a “proper gravel” course.
Reflecting on the early detection that saved his life, Irvine shares a blunt message echoed by his medical team: “The biggest problem with testicular cancer is that when boys feel something’s wrong, we just don’t do anything about it. We caught it super early, that was what saved me.” With his health restored and his competitive hunger sharp, Irvine is once again pushing his limits across both road and gravel calendars.
Related reading
